HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-intensity laser and photodynamic therapy as a treatment for recurrent herpes labialis.

AbstractOBJECTIVE:
The aim of this study was to report the treatment of recurrent herpes labialis (RHL) using a high-intensity laser or methylene blue (MB)-mediated photodynamic therapy (PDT) in combination with low-level laser therapy (LLLT).
MATERIALS AND METHODS:
Four clinical cases of patients diagnosed with RHL are described in this report. Two patients were subjected to high-intensity laser therapy (HILT) followed by LLLT, and two patients received MB-mediated PDT, again followed by LLLT. LLLT was conducted at 24, 48, 72 h, and 7 d after HILT or PDT. Patients were followed up after 6 mo.
RESULTS:
Throughout the follow-up period, all patients reported pain relief and did not show any signs or symptoms of RHL. A favorable healing process was observed in all cases. None of the patients reported pain as a consequence of the treatment.
CONCLUSION:
These results suggest that HILT and MB-mediated PDT, in combination with LLLT, may constitute a benefit when treating vesicles in RHL.
AuthorsJuliana Marotti, Felipe Fornias Sperandio, Eduardo Rodrigues Fregnani, Ana Cecilia Corrêa Aranha, Patrícia Moreira de Freitas, Carlos de Paula Eduardo
JournalPhotomedicine and laser surgery (Photomed Laser Surg) Vol. 28 Issue 3 Pg. 439-44 (Jun 2010) ISSN: 1557-8550 [Electronic] United States
PMID19821702 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Combined Modality Therapy
  • Female
  • Herpes Labialis (radiotherapy)
  • Humans
  • Laser Therapy
  • Low-Level Light Therapy
  • Male
  • Photochemotherapy
  • Recurrence
  • Wound Healing (radiation effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: